4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow batefenterol: new trials by email Literature Review of batefenterol trials Research Report on batefenterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination GSK961081, Fluticasone furoate - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 48 | 2014-02-19 | 2017-05-15 |
| A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers GSK961081, GSK961081 matching placebo, Propranolol - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | Theravance Biopharma | 23 | 2008-03-10 | 2021-10-06 |
| Succinate Salt Version of GSK961081 for Healthy Volunteers GSK961081, GSK961081 matching placebo - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | Theravance Biopharma | 18 | 2007-11-29 | 2021-10-06 |
| Study of GSK961081 in Healthy Volunteer Subjects GSK961081 15mcg SD, GSK961081 3mcg SD, GSK961081 50mcg SD - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | Theravance Biopharma | 46 | 2005-11-07 | 2021-10-06 |
Pulmonary Disease, Chronic Obstructive (4)
Theravance Biopharma (3) · GlaxoSmithKline (1)
United Kingdom (3) · Australia (1)